Skyway Capital Markets Advises SPAC on $85 Million Medical Technology Merger
TAMPA, Fla.--(BUSINESS WIRE)--Skyway Capital Markets, LLC (“Skyway”) is pleased to announce the merger of SeaStar Medical, Inc. (“SeaStar Medical”), a...
TAMPA, Fla.--(BUSINESS WIRE)--Skyway Capital Markets, LLC (“Skyway”) is pleased to announce the merger of SeaStar Medical, Inc. (“SeaStar Medical”), a...
LUND, SWEDEN / ACCESSWIRE / May 2, 2022 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F)Spago Nanomedical AB (publ) has received notice from the...
-- Data Demonstrate Rapid and Complete Wound Healing, with Six of Eight (75%) Patients Achieving Complete Healing within Four Weeks;...
TORONTO, May 01, 2022 (GLOBE NEWSWIRE) -- Today marks the first day of Brain Cancer Awareness month. On this day...
New data highlights include: - Phase 3 open-label extension study data for growth hormone-deficient children treated for 2.5 years with TransConTM...
In accordance with Section 32 of the Danish Capital Markets Act, GN Store Nord is required to publish the total...
Oticon demonstrates its unwavering prowess in product design, achieving not one, but two internationally recognised awards for good design for...
Caution: The iLet® Bionic Pancreas is an investigational device limited by Federal (or United States) law to investigational use. Not...
PRESS RELEASE April 30, 2022 Saniona (OMX: SANION), a clinical-stage biopharmaceutical company focused on rare diseases, today announced that the...
IRVINE, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet...
TORONTO, April 29, 2022 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical...
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES Company reports strong revenue growth of 22%...
First novel, nonstimulant option for adults with ADHD in 20 yearsADHD affects an estimated 10 million adults in the U.S.ROCKVILLE,...
ORGOVYX® is the first and only oral androgen deprivation therapy for advanced hormone-sensitive prostate cancer in EuropeMyovant expects to secure...
CARLSBAD, Calif, April 29, 2022 (GLOBE NEWSWIRE) -- NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE...
The study achieved the primary endpoint of reduction in nodule hardness at 12 months and secondary endpoint of reduction in...
VANCOUVER, BC / ACCESSWIRE / April 29, 2022 / Lotus Ventures Inc. (CSE:J)(OTC PINK:LTTSF) ("Lotus" or the "Company"), a premium...
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - April 29, 2022) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN), will report financial...
FDA-cleared HeartKey® 2.0 launches to power next generation of medical and consumer devices and platforms SAN FRANCISCO--(BUSINESS WIRE)--Global heart health...
This acquisition further underscores HST’s longstanding commitment to enhancing ASC technology and delivering improved patient outcomes across the industry. NASHVILLE--(BUSINESS...